A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)
Clinical trial NCT06834789 · COMPLETED
Trial details
- NCT number
- NCT06834789
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-18
- Primary completion
- 2025-11-03
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.